Atlas Trials

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Clinical trial NCT03802617 · COMPLETED

Trial details

NCT number
NCT03802617
Sponsor
Kissei Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Uremic Pruritus
Start date
2019-02-01
Primary completion
2019-10-22
Enrollment
247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.